TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33358790

Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR; 29.1% CP, 17.3% fat; 1.5% of BW as DM for wk 1, 2% of BW as DM wk 2‐5, 1% of BW as DM wk 6) plus conventional starter; n = 12 calves
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR) plus high‐CP starter (HCS; 26% CP, DM basis); n = 14 calves
Number of subjects: 45

Group type: COMPARATOR
Intervention: High rate of milk replacer (HMR) plus conventional starter (CCS; 21.5% CP, DM basis); n = 12 calves
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR); n = 12 calves
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR + HCS); n = 14 calves
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High rate of milk replacer (HMR treatments); n = 12 calves
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low rate of milk replacer (LMR; 20.6% CP, 21.7% fat; 1.25% of BW as DM) plus conventional starter (CCS; 21.5% CP, DM basis); n = 11 calves
Number of subjects: 45
Study: 36083793

Group type: EXPERIMENTAL
Intervention: Allogeneic cardiosphere-derived cell (CDC) therapy (20 × 10^6 CDCs)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Allogeneic cardiosphere-derived cell (CDC) therapy with cyclosporine (2.5 mg/kg iv and 100 mg/day po)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 29
Study: 32071281

Group type: EXPERIMENTAL
Intervention: Treat-to-target approach in PsA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tight Control of Psoriatic Arthritis study
Number of subjects: 0
Study: 32942924

Group type: EXPERIMENTAL
Intervention: HH subjects with arthritis
Number of subjects: 119
Study: 34498497

Group type: EXPERIMENTAL
Intervention: Sibling support group focused on autism spectrum disorder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Similar group without a focus on autism spectrum disorder
Number of subjects: 0
Study: 33781617

Group type: EXPERIMENTAL
Intervention: Community health worker-led multicomponent intervention (health education, monthly telephone follow-ups, navigation assistance)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Community health worker-led multicomponent intervention
Number of subjects: 387
Study: 35779560

Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg once daily if <100 kg, 40 mg twice daily if ≥100 kg) for 21 days
Number of subjects: 219

Group type: COMPARATOR
Intervention: Standard of care (no enoxaparin)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 219

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 219
Study: 33121228

Group type: EXPERIMENTAL
Intervention: Norepinephrine (NE) infusion (8 µg/min)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Phenylephrine (PE) infusion (100 µg/min)
Number of subjects: 62
Study: 33317488

Group type: EXPERIMENTAL
Intervention: ready4life coaching program
Number of subjects: 1318

Group type: COMPARATOR
Intervention: assessment only control group
Number of subjects: 1318
Study: 35224034

Group type: EXPERIMENTAL
Intervention: Home-based Baduanjin exercise (5 times a week for 12 weeks)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Moderate intensity aerobic walking (5 times a week for 12 weeks)
Number of subjects: 114
Study: 35222890

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Locking proximal humeral plate (LPHP)
Number of subjects: 60
Study: 33926403

Group type: EXPERIMENTAL
Intervention: Azithromycin 1-59
Number of subjects: 3350

Group type: EXPERIMENTAL
Intervention: Azithromycin 1-11
Number of subjects: 3350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3350
Study: 32620262

Group type: EXPERIMENTAL
Intervention: High-dose TXA (50 mg kg−1 followed by 5 mg kg−1 h−1)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Low-dose TXA (10 mg kg−1 followed by 5 mg kg−1 h−1)
Number of subjects: 68
Study: 33111247

Group type: EXPERIMENTAL
Intervention: Exercise training intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 62
Study: 36377259

Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM) intervention
Number of subjects: 158

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 158
Study: 34235608

Group type: EXPERIMENTAL
Intervention: ConnectedCancerCare (CCC)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Static online survivorship care plan (control)
Number of subjects: 66
Study: 32186106

Group type: EXPERIMENTAL
Intervention: Gua Sha therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham scraping
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 36494329

Group type: EXPERIMENTAL
Intervention: SOM3355 (bevantolol hydrochloride) 200 mg twice daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SOM3355 (bevantolol hydrochloride)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33067856

Group type: EXPERIMENTAL
Intervention: Drink Less app (recommended via email)
Number of subjects: 5562

Group type: COMPARATOR
Intervention: NHS alcohol advice webpage (comparator)
Number of subjects: 5562
Study: 32199156

Group type: EXPERIMENTAL
Intervention: Alcohol dose of 0.45 g/kg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Alcohol dose of 0.65 g/kg
Number of subjects: 160

Group type: COMPARATOR
Intervention: No exposure to in-vehicle alcohol feedback device
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Exposure to in-vehicle alcohol feedback device
Number of subjects: 160
Study: 34287079

Group type: EXPERIMENTAL
Intervention: Non-resident completed suicides
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Thematic analysis of 30 death notes
Number of subjects: 303

Group type: COMPARATOR
Intervention: Comparison with resident cases
Number of subjects: 303
Study: 32999419

Group type: COMPARATOR
Intervention: Breastfeeding (never breastfed)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Longer breastfeeding duration
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Maternal uncontrolled eating
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Maternal emotional eating
Number of subjects: 230
Study: 36307858

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 58
Study: 33892983

Group type: EXPERIMENTAL
Intervention: Microplanning verification process
Number of subjects: 36
Study: 32221819

Group type: EXPERIMENTAL
Intervention: Voluntary peer educators
Number of subjects: 966

Group type: COMPARATOR
Intervention: Peer nominated peer educators
Number of subjects: 966
Study: 34467621

Group type: EXPERIMENTAL
Intervention: Dietary diversity score (DDS) derived from the Minimum Dietary Diversity for Women 10-item scale
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Wealth quintile as a social determinant of nutrition
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Dietary diversification and nutrition education strategies
Number of subjects: 390
Study: 33385533

Group type: EXPERIMENTAL
Intervention: Resin Infiltration (Icon)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Fluoride Varnish (Duraphat)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Fluoride Varnish (Duraphat) after enamel etching with 37% phosphoric acid
Number of subjects: 51
Study: 36454345

Group type: EXPERIMENTAL
Intervention: One‐Shot Dilatation (Group A)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Serial Dilatation (Group B)
Number of subjects: 129
Study: 33501942

Group type: EXPERIMENTAL
Intervention: Donor fecal microbiota transplantation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (autologous transplant)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Donor fecal microbiota transplantation (subgroup analysis)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (subgroup analysis)
Number of subjects: 26
Study: 35148378

Group type: EXPERIMENTAL
Intervention: Cefiderocol
Number of subjects: 34

Group type: COMPARATOR
Intervention: Best available therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: High-dose meropenem
Number of subjects: 34
Study: 33685512

Group type: EXPERIMENTAL
Intervention: Complex intervention
Number of subjects: 165397

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 165397
Study: 32020356

Group type: EXPERIMENTAL
Intervention: Exercise intervention (EX, n=19)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Health education intervention (HE, n=18)
Number of subjects: 37
Study: 36151535

Group type: EXPERIMENTAL
Intervention: Precision Family Spirit (PFS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Family Spirit (Standard FS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (PFS and Standard FS)
Number of subjects: 60
Study: 32358349

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with conventional therapy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 66
Study: 34989759

Group type: EXPERIMENTAL
Intervention: Flower essence therapy (4 drops, 4 times a day for 60 days)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (4 drops, 4 times a day for 60 days)
Number of subjects: 101
Study: 35029097

Group type: EXPERIMENTAL
Intervention: Digital workflow group (prefabricated prostheses with anchor pin attachment system)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conventional workflow group (conventional procedure for provisional prosthesis)
Number of subjects: 6
Study: 34849651

Group type: EXPERIMENTAL
Intervention: Standard ATT plus daily 1000 mg metformin (METRIF)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Standard ATT (HREZ)
Number of subjects: 322
Study: 32979939

Group type: EXPERIMENTAL
Intervention: High-dose varenicline (1 mg twice daily; 0.5 mg twice daily if bodyweight ≤55 kg)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Low-dose varenicline (0.5 mg twice daily; 0.5 mg once daily if bodyweight ≤55 kg)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study: 35017115

Group type: EXPERIMENTAL
Intervention: Treatment of anal HSIL
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active monitoring
Number of subjects: 0
Study: 32763541

Group type: EXPERIMENTAL
Intervention: Sertraline plus enhanced medication management (EMM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PE plus placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PE plus sertraline hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 0
Study: 34190422

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) at doses of 600 or 1000 mg per day for 12 weeks
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 405
Study: 34780511

Group type: EXPERIMENTAL
Intervention: Evening Restriction intervention (no screen media use after six pm)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: General Restrict intervention (limit entertainment-based screen media to three hours/week/person)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: General Restrict intervention
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Accelerometry wear protocol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Recruitment strategy
Number of subjects: 12
Study: 33749975

Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide (TrA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intralesional methotrexate (MTX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (TrA and MTX)
Number of subjects: 40
Study: 34382289

Group type: EXPERIMENTAL
Intervention: Musculoskeletal pain
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Headache
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Fever
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Abdominal pain
Number of subjects: 486
Study: 34065454

Group type: EXPERIMENTAL
Intervention: Wu-style Tai Chi (60 min, 3 times a week for 6 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Simplified Tai Chi (3 times a week for 6 weeks)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Wu-style Tai Chi
Number of subjects: 66
Study: 34516033

Group type: EXPERIMENTAL
Intervention: Vitamin D replacement (n=21)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Core and balance exercises (n=18)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Vitamin D replacement plus core and balance exercises (n=20)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Core and balance exercises (n=40) - Control group
Number of subjects: 59
Study: 34964262

Group type: EXPERIMENTAL
Intervention: Metformin during pregnancy
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Post partum metformin concentration
Number of subjects: 73
Study: 34060169

Group type: EXPERIMENTAL
Intervention: Health literacy education (four weekly training sessions)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (no health literacy education)
Number of subjects: 206
Study: 32233704

Group type: EXPERIMENTAL
Intervention: Lactate
Number of subjects: 1338

Group type: COMPARATOR
Intervention: pH
Number of subjects: 1338
Study: 36477274

Group type: EXPERIMENTAL
Intervention: Allis clamp
Number of subjects: 95

Group type: COMPARATOR
Intervention: Single-tooth tenaculum
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Allis clamp and Single-tooth tenaculum
Number of subjects: 95
Study: 33141277

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic surgery (SPLS)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Multiport laparoscopic surgery (MPLS)
Number of subjects: 359
Study: 32380679

Group type: EXPERIMENTAL
Intervention: Dynamic balance exercises with visual feedback (VF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dynamic balance exercises without visual feedback (control)
Number of subjects: 30
Study: 34508365

Group type: EXPERIMENTAL
Intervention: Treatment reminders (outpatient appointment reminders a day before appointment and medication reminders on a weekly basis)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Standard treatment without reminders
Number of subjects: 183
Study: 33929052

Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy (LiST) applied once weekly for 6 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy (LiST) applied twice weekly for 3 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison between once weekly and twice weekly LiST
Number of subjects: 50
Study: 35300814

Group type: EXPERIMENTAL
Intervention: Pelacarsen (20-80 mg cumulative monthly doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pelacarsen
Number of subjects: 0
Study: 34066319

Group type: EXPERIMENTAL
Intervention: Eight-session multicomponent intervention program based on group psychological therapy and adventure activities
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (details of control not specified)
Number of subjects: 34
Study: 34863926

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Both MP and CBT
Number of subjects: 15
Study: 34689452

Group type: EXPERIMENTAL
Intervention: 5,000 ppm sodium fluoride (F5000)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 1,450 ppm sodium fluoride (F1450)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (deionized water)
Number of subjects: 150
Study: 32380852

Group type: EXPERIMENTAL
Intervention: 12-month home-based exercise program with four physiotherapy follow-up visits
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard postoperative exercise instructions
Number of subjects: 45
Study: 35175414

Group type: EXPERIMENTAL
Intervention: Intravenous scopolamine before stapling
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33125080

Group type: EXPERIMENTAL
Intervention: GHRH
Number of subjects: 61

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 61
Study: 33852380

Group type: EXPERIMENTAL
Intervention: Passive military exoskeleton
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mass-matched control condition
Number of subjects: 0
Study: 34569421

Group type: EXPERIMENTAL
Intervention: Vertical closure of the vaginal cuff
Number of subjects: 0

Group type: COMPARATOR
Intervention: Horizontal closure of the vaginal cuff
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both techniques (Vertical and Horizontal closure)
Number of subjects: 0
Study: 35230177

Group type: EXPERIMENTAL
Intervention: PartyWise intervention (telephone screening, brief counseling, web-based resources, and up to 8 weekly text messages)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: PartyWise intervention
Number of subjects: 520

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 520
Study: 33549112

Group type: EXPERIMENTAL
Intervention: Breastfeeding duration > 6 months
Number of subjects: 10464

Group type: COMPARATOR
Intervention: Neonatal and familial risk factors
Number of subjects: 10464
Study: 35705264

Group type: EXPERIMENTAL
Intervention: Bilateral posterior quadratus lumborum block (QLB) with 20 mL of 0.375% ropivacaine on each side (150 mg total)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Intrathecal morphine (0.4 mg morphine sulfate)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Bilateral posterior quadratus lumborum block (QLB)
Number of subjects: 56
Study: 33300420

Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low-intensity strength training without BFR (Control)
Number of subjects: 18
Study: 35337143

Group type: EXPERIMENTAL
Intervention: Chisan®/ADAPT‐232 (a fixed combination of adaptogens Rhodiola, Eleutherococcus, and Schisandra) supplementation for two weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Chisan® treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33411684

Group type: EXPERIMENTAL
Intervention: Bi-directional Mendelian randomization (MR) analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cFDR method
Number of subjects: 0
Study: 35181380

Group type: EXPERIMENTAL
Intervention: Combined Nutri- and Eco-Score at product level
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Recommendation agents
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Display of average impact scores of the selected basket and social norms
Number of subjects: 1000
Study: 32441643

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) administered subcutaneously at 162 mg every 1 or 2 weeks in the GiACTA trial.
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) administered via standard IV dose (8 mg/kg/month) or subcutaneously (162 mg/week) in clinical practice.
Number of subjects: 385

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 385
Study: 35956412

Group type: EXPERIMENTAL
Intervention: Study formulation (A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study formulation + eye lubricant (A + L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo + eye lubricant (P + L)
Number of subjects: 0
Study: 34963483

Group type: EXPERIMENTAL
Intervention: mHealth coaching via a smartphone application alongside usual care
Number of subjects: 800

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 800
Study: 36131346

Group type: EXPERIMENTAL
Intervention: Fully vaccinated individuals aged 18-64
Number of subjects: 2419

Group type: COMPARATOR
Intervention: Unvaccinated individuals aged 18-64
Number of subjects: 2419

Group type: EXPERIMENTAL
Intervention: Vaccinated individuals aged 45-64
Number of subjects: 2419

Group type: EXPERIMENTAL
Intervention: Vaccinated individuals aged 18-25
Number of subjects: 2419
Study: 33901754

Group type: EXPERIMENTAL
Intervention: Forest exposure (monoterpenes: alpha‐pinene, beta‐pinene, alpha‐phellandrene, limonene)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (urban environment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Forest exposure
Number of subjects: 0
Study: 32175881

Group type: EXPERIMENTAL
Intervention: Active tcVNS stimulation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 26
Study: 33523037

Group type: EXPERIMENTAL
Intervention: Equine riding (EQG, n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CON, n=15)
Number of subjects: 30
Study: 34151544

Group type: EXPERIMENTAL
Intervention: Conical connection systems
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Straight connection systems
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 56
Study: 32690008

Group type: EXPERIMENTAL
Intervention: Protocol-guided interactive Visual Telehealth Consultation (VTC) for clinical decision-making, plus telephone follow-up.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ACE service in ED responding to RACFs with protocol-guided VTC.
Number of subjects: 16
Study: 33098739

Group type: EXPERIMENTAL
Intervention: ABC intervention (N=32)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 76

Group type: COMPARATOR
Intervention: DEF intervention (N=44)
Number of subjects: 76
Study: 32284323

Group type: EXPERIMENTAL
Intervention: Management of diabetes in kidney transplant patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Management of secondary hyperparathyroidism in kidney transplant patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Management of obesity in kidney transplant patients
Number of subjects: 0
Study: 35728892

Group type: EXPERIMENTAL
Intervention: Guideline implementation tool arm
Number of subjects: 535

Group type: COMPARATOR
Intervention: Usual care control arm
Number of subjects: 535
Study: 35866833

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine (first-line chemotherapy)
Number of subjects: 56

Group type: COMPARATOR
Intervention: HT group
Number of subjects: 56
Study: 33639007

Group type: EXPERIMENTAL
Intervention: Proximal nontouch biofield therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham session
Number of subjects: 64
Study: 35565731

Group type: EXPERIMENTAL
Intervention: Resveratrol 75 mg twice daily for three months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62